TFF Pharmaceuticals announces voluntary delisting from Nasdaq
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2025
0mins
Company Delisting Announcement: TFF Pharmaceuticals has notified The Nasdaq Stock Market of its intent to voluntarily delist its common stock, with plans to file a Form 25 around February 16.
Liquidation Plans: The delisting is part of the company's strategy for liquidation and dissolution, and there are no arrangements for listing on any other exchange.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
